Background The nucleotide analogue prodrug remdesivir was among the first antiviral therapies
to be tested in randomized controlled trials (RCTs) for COVID-19. We performed a meta-…

A stable latent reservoir for HIV-1 in resting CD4 + T cells is the principal barrier to a cure 1 ,
2 – 3 . Curative strategies that target the reservoir are being tested 4 , 5 and require accurate…

Background People living with human immunodeficiency virus (HIV) may have numerous
risk factors for acquiring coronavirus disease 2019 (COVID-19) and developing severe …

Mammalian orthoreoviruses (reoviruses) are highly tractable experimental models for
studies of double-stranded (ds) RNA virus replication and pathogenesis. Reoviruses infect …

Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific
(SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral …

Diverse families of viruses bind immunoglobulin superfamily (IgSF) proteins located in tight
junctions (TJs) and adherens junctions of epithelium and endothelium. However, little is …

Proliferation of CD4 + T cells harboring HIV-1 proviruses is a major contributor to viral
persistence in people on antiretroviral therapy (ART). To determine whether differential rates of …

PLWH should be aware that new or worsening symptoms following SARS-CoV-2 infection
might represent Long COVID. HIV providers should be aware of this clinical entity and be …

Background Outpatient coronavirus disease 2019 (COVID-19) has been insufficiently
characterized. To determine the progression of disease and determinants of hospitalization, we …

Background: Predicting the clinical trajectory of individual patients hospitalized with
coronavirus disease 2019 (COVID-19) is challenging but necessary to inform clinical care. The …